Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0004377 | HP:0004377 | Hematological neoplasm | 0 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0004377 | Hematological neoplasm | 0 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004377 | Hematological neoplasm | 0 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004377 | Hematological neoplasm | 0 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004377 | Hematological neoplasm | 0 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004377 | Hematological neoplasm | 0 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0002863 | Myelodysplasia | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0002665 | Lymphoma | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0006782 | Malignant eosinophil proliferation | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0001909 | Leukemia | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0002665 | Lymphoma | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0006782 | Malignant eosinophil proliferation | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0001909 | Leukemia | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0002863 | Myelodysplasia | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0011857 | Plasmacytoma | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005523 | Lymphoproliferative disorder | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0006775 | Multiple myeloma | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0011857 | Plasmacytoma | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005523 | Lymphoproliferative disorder | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0006775 | Multiple myeloma | 1 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0002665 | Lymphoma | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0006782 | Malignant eosinophil proliferation | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0001909 | Leukemia | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0002863 | Myelodysplasia | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0002665 | Lymphoma | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0006782 | Malignant eosinophil proliferation | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0001909 | Leukemia | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0002863 | Myelodysplasia | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0011857 | Plasmacytoma | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005523 | Lymphoproliferative disorder | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0006775 | Multiple myeloma | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0011857 | Plasmacytoma | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005523 | Lymphoproliferative disorder | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0006775 | Multiple myeloma | 1 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0002665 | Lymphoma | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0006782 | Malignant eosinophil proliferation | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0001909 | Leukemia | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0002863 | Myelodysplasia | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0002665 | Lymphoma | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0006782 | Malignant eosinophil proliferation | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0001909 | Leukemia | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0002863 | Myelodysplasia | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0011857 | Plasmacytoma | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005523 | Lymphoproliferative disorder | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0006775 | Multiple myeloma | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0011857 | Plasmacytoma | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005523 | Lymphoproliferative disorder | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0006775 | Multiple myeloma | 1 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005547 | Myeloproliferative disorder | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005558 | Chronic leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012148 | Multiple lineage myelodysplasia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012189 | Hodgkin lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0011953 | Pulmonary lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005547 | Myeloproliferative disorder | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005558 | Chronic leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012148 | Multiple lineage myelodysplasia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012189 | Hodgkin lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0011953 | Pulmonary lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0002488 | Acute leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012149 | Bilineage myelodysplasia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012150 | Single lineage myelodysplasia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0045038 | Gastric lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005526 | Lymphoid leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012539 | Non-Hodgkin lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012324 | Myeloid leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005508 | Monoclonal immunoglobulin M proteinemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0002488 | Acute leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012149 | Bilineage myelodysplasia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012150 | Single lineage myelodysplasia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0045038 | Gastric lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005526 | Lymphoid leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012539 | Non-Hodgkin lymphoma | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012324 | Myeloid leukemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005508 | Monoclonal immunoglobulin M proteinemia | 2 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005547 | Myeloproliferative disorder | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005558 | Chronic leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012148 | Multiple lineage myelodysplasia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012189 | Hodgkin lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0011953 | Pulmonary lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005558 | Chronic leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012148 | Multiple lineage myelodysplasia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012189 | Hodgkin lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0011953 | Pulmonary lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005547 | Myeloproliferative disorder | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0002488 | Acute leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012149 | Bilineage myelodysplasia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012150 | Single lineage myelodysplasia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0045038 | Gastric lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005526 | Lymphoid leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012539 | Non-Hodgkin lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012324 | Myeloid leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005508 | Monoclonal immunoglobulin M proteinemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012149 | Bilineage myelodysplasia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012150 | Single lineage myelodysplasia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0045038 | Gastric lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005526 | Lymphoid leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012539 | Non-Hodgkin lymphoma | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012324 | Myeloid leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005508 | Monoclonal immunoglobulin M proteinemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0002488 | Acute leukemia | 2 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005558 | Chronic leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012148 | Multiple lineage myelodysplasia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012189 | Hodgkin lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0011953 | Pulmonary lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005547 | Myeloproliferative disorder | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005558 | Chronic leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012148 | Multiple lineage myelodysplasia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012189 | Hodgkin lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0011953 | Pulmonary lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005547 | Myeloproliferative disorder | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012149 | Bilineage myelodysplasia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012150 | Single lineage myelodysplasia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0045038 | Gastric lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005526 | Lymphoid leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012539 | Non-Hodgkin lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012324 | Myeloid leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005508 | Monoclonal immunoglobulin M proteinemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0002488 | Acute leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012150 | Single lineage myelodysplasia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0045038 | Gastric lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005526 | Lymphoid leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012539 | Non-Hodgkin lymphoma | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012324 | Myeloid leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005508 | Monoclonal immunoglobulin M proteinemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0002488 | Acute leukemia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012149 | Bilineage myelodysplasia | 2 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004836 | Acute promyelocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0006721 | Acute lymphoblastic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012190 | T-cell lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005506 | Chronic myelogenous leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0004828 | Refractory anemia with ringed sideroblasts | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0006733 | Acute megakaryocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005539 | T cell chronic lymphocytic lymphoma/leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012191 | B-cell lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0004808 | Acute myeloid leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012325 | Chronic myelomonocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0030080 | Burkitt lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0006721 | Acute lymphoblastic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012190 | T-cell lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005506 | Chronic myelogenous leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004828 | Refractory anemia with ringed sideroblasts | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0006733 | Acute megakaryocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005539 | T cell chronic lymphocytic lymphoma/leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012191 | B-cell lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004808 | Acute myeloid leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012325 | Chronic myelomonocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0030080 | Burkitt lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004836 | Acute promyelocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0030069 | Primary central nervous system lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005531 | Biphenotypic acute leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005534 | Transient myeloproliferative syndrome | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005550 | Chronic lymphatic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0004845 | Acute monocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0004820 | Acute myelomonocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012209 | Juvenile myelomonocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0030069 | Primary central nervous system lymphoma | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005531 | Biphenotypic acute leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005534 | Transient myeloproliferative syndrome | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005550 | Chronic lymphatic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004845 | Acute monocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004820 | Acute myelomonocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012209 | Juvenile myelomonocytic leukemia | 3 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0006721 | Acute lymphoblastic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012190 | T-cell lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005506 | Chronic myelogenous leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004828 | Refractory anemia with ringed sideroblasts | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0006733 | Acute megakaryocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005539 | T cell chronic lymphocytic lymphoma/leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012191 | B-cell lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004808 | Acute myeloid leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012325 | Chronic myelomonocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0030080 | Burkitt lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004836 | Acute promyelocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0006721 | Acute lymphoblastic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012190 | T-cell lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005506 | Chronic myelogenous leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004828 | Refractory anemia with ringed sideroblasts | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0006733 | Acute megakaryocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005539 | T cell chronic lymphocytic lymphoma/leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012191 | B-cell lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004808 | Acute myeloid leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012325 | Chronic myelomonocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0030080 | Burkitt lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004836 | Acute promyelocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0030069 | Primary central nervous system lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005531 | Biphenotypic acute leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005534 | Transient myeloproliferative syndrome | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005550 | Chronic lymphatic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004845 | Acute monocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004820 | Acute myelomonocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012209 | Juvenile myelomonocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005531 | Biphenotypic acute leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005534 | Transient myeloproliferative syndrome | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005550 | Chronic lymphatic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004845 | Acute monocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004820 | Acute myelomonocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012209 | Juvenile myelomonocytic leukemia | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0030069 | Primary central nervous system lymphoma | 3 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0006721 | Acute lymphoblastic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012190 | T-cell lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005506 | Chronic myelogenous leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004828 | Refractory anemia with ringed sideroblasts | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0006733 | Acute megakaryocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005539 | T cell chronic lymphocytic lymphoma/leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012191 | B-cell lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004808 | Acute myeloid leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012325 | Chronic myelomonocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0030080 | Burkitt lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004836 | Acute promyelocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012190 | T-cell lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005506 | Chronic myelogenous leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004828 | Refractory anemia with ringed sideroblasts | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0006733 | Acute megakaryocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005539 | T cell chronic lymphocytic lymphoma/leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012191 | B-cell lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004808 | Acute myeloid leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012325 | Chronic myelomonocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0030080 | Burkitt lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004836 | Acute promyelocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0006721 | Acute lymphoblastic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005531 | Biphenotypic acute leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005534 | Transient myeloproliferative syndrome | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005550 | Chronic lymphatic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004845 | Acute monocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004820 | Acute myelomonocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012209 | Juvenile myelomonocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0030069 | Primary central nervous system lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005534 | Transient myeloproliferative syndrome | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005550 | Chronic lymphatic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004845 | Acute monocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004820 | Acute myelomonocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012209 | Juvenile myelomonocytic leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0030069 | Primary central nervous system lymphoma | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005531 | Biphenotypic acute leukemia | 3 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004848 | Ph-positive acute lymphoblastic leukemia | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012192 | Cutaneous T-cell lymphoma | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0004848 | Ph-positive acute lymphoblastic leukemia | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012192 | Cutaneous T-cell lymphoma | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004812 | B Acute Lymphoblastic Leukemia | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0012193 | Anaplastic large-cell lymphoma | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0006727 | T-cell acute lymphoblastic leukemias | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0005517 | T-cell lymphoma/leukemia | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0033125 | Follicular lymphoma | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3763 | 7127 | 120436 |
HP:0004377 | HP:0004812 | B Acute Lymphoblastic Leukemia | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0012193 | Anaplastic large-cell lymphoma | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0006727 | T-cell acute lymphoblastic leukemias | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0005517 | T-cell lymphoma/leukemia | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0033125 | Follicular lymphoma | 4 | MLH1 CL E G H | 4292 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 3540 | 7127 | 120436 |
HP:0004377 | HP:0004848 | Ph-positive acute lymphoblastic leukemia | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012192 | Cutaneous T-cell lymphoma | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004848 | Ph-positive acute lymphoblastic leukemia | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012192 | Cutaneous T-cell lymphoma | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004812 | B Acute Lymphoblastic Leukemia | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0012193 | Anaplastic large-cell lymphoma | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0006727 | T-cell acute lymphoblastic leukemias | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0005517 | T-cell lymphoma/leukemia | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0033125 | Follicular lymphoma | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4964 | 7325 | 609309 |
HP:0004377 | HP:0004812 | B Acute Lymphoblastic Leukemia | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0012193 | Anaplastic large-cell lymphoma | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0006727 | T-cell acute lymphoblastic leukemias | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0005517 | T-cell lymphoma/leukemia | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0033125 | Follicular lymphoma | 4 | MSH2 CL E G H | 4436 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 4607 | 7325 | 609309 |
HP:0004377 | HP:0004848 | Ph-positive acute lymphoblastic leukemia | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012192 | Cutaneous T-cell lymphoma | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004848 | Ph-positive acute lymphoblastic leukemia | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012192 | Cutaneous T-cell lymphoma | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0004812 | B Acute Lymphoblastic Leukemia | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0012193 | Anaplastic large-cell lymphoma | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0006727 | T-cell acute lymphoblastic leukemias | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0005517 | T-cell lymphoma/leukemia | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0033125 | Follicular lymphoma | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 6219 | 7329 | 600678 |
HP:0004377 | HP:0004812 | B Acute Lymphoblastic Leukemia | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0012193 | Anaplastic large-cell lymphoma | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0006727 | T-cell acute lymphoblastic leukemias | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0005517 | T-cell lymphoma/leukemia | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |
HP:0004377 | HP:0033125 | Follicular lymphoma | 4 | MSH6 CL E G H | 2956 | 587 | Al Gazali Sabrinathan Nair syndrome | | | ORPHA | 0 | | 5717 | 7329 | 600678 |